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Wednesday, February 29, 2012 667aand will explore pharmacologic modulation of EGFR as well as protein tyro-
sine phosphatases.
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Epidermal growth factor receptor is known as a key cell membrane receptor to
stimulate cancer when overexpressed or malfunctioned. It is activated and di-
merized by binding to epidermal growth factors, and then may further cluster
and be internalized by the cell. However, the EGFR inhibitor drugs have
only ~10% response rate from unselected population in clinics. Accurate in-
spection by our high-resolution imaging technique in the spatial organization
of the receptors may provide significant insight into the mechanisms
of resistance. We showed in breast cancer cells the endocytosis of EGFR and
co-clustering of EGFR and HGFR with 2-photon 3D imaging. We used
super-resolution imaging to evaluate the aggregation of EGFR and measure
the separation of them in dimers and oligomers. We will also investigate the
correlation between the EGFR aggregation and the MAPK pathway signaling,
as well as distances in EGFR/HGFR heterodimers. Based on the results, we can
build up a quantitative, multivariate model to explain the EGFR inhibitor resis-
tance and optimize cancer therapy.
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Co-clustering of multiple cell signaling molecules is commonly thought to af-
fect cellular signal output. While current experimental methods allow the ob-
servation of molecular organization, unequivocally establishing the function
of molecular organization has been troublesome since methods for altering it
are lacking. We have developed a novel method for dimerizing biomolecules
on supported lipid bilayers, a system commonly used to present juxtacrine sig-
naling ligands to cells. Using fluorescence cross-correlation spectroscopy, we
demonstrate co-diffusion of fluorescent molecules, and thus the successful for-
mation of our heterodimer. We are employing this approach to study receptor
cross-talk between EGFR and EphA2. These two receptor tyrosine kinases are
often overexpressed together in metastatic breast cancer cells, and have been
reported to colocalize at the cell membrane and physically interact. However,
the consequences of this interaction are unclear. We are currently probing the
effects of EphA2 and EGFR co-clustering in MDA-MB-231 cells using this
novel ‘‘designer cluster’’ approach. The experimental platform presented
here will elucidate the role of scaffolding and spatial organization in signaling
pathway cross-talk by probing these systems in ways previously not possible.
3388-Pos Board B249
Determining if Spatio-Mechanosensitivity of EphA2 Signaling Stems from
Physical Impedance of Endocytosis
Adrienne C. Greene, Samuel J. Lord, I. Jeena Lee, Jay T. Groves.
The University of California Berkeley, Berkeley CA, CA, USA.
We recently found that the spatial organization of the receptor tyrosine kinase
EphA2 plays a key role in signal transduction in breast epithelial cancer cells.
Upon stimulation from its native ligand ephrinA1 bound to a supported lipid
membrane, EphA2 is spatially reorganized into large clusters at the cancer
cell and supported membrane junction. Patterning nanostructures on the sup-
ported membrane substrate, using a spatial mutation technique, imposes phys-
ical restrictions to ligands bound to the supported membrane (i.e. ephrinA1).
We used this strategy to restrict the movement of EphA2-ephrinA1 clusters
and discovered alterations in downstream signaling events as a function of
EphA2 organization. In particular, recruitment of the disintegrin and metallo-
protease 10 (ADAM10) to the clusters is inhibited. ADAM10 has been impli-
cated in the cleavage and subsequent endocytosis of other ephrin ligands, and
may play a role in the endocytosis of EphA2-ephrinA1. Here we report that
dynamin2, a large GTPase involved in the scission of endocytic vesicles, isrecruited to the EphA2-ephrinA1 clusters. Preliminary evidence suggests that
clathrin-mediated endocytosis (CME) is involved in the initial endocytosis of
EphA2-ephrinA1. Finally, we have also found that the function of ADAM10
is necessary for ephrinA1 endocytosis. The implications of these observations
for spatial regulation of EphA2 signaling will be discussed.
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Our research focuses on the spatial reorganization of receptors and ligands that
occurs at the cell-cell interface during juxtracine signaling. Our unique experi-
mental platform, live cells interfacedwith supported lipid bilayers, is a simplified
and controllable system that recapitulates essential aspects of the cell-cell con-
tact. To probe how protein organization in the membrane influences signaling
in the cell, we pattern the supported lipid bilayer into microscale corrals that re-
strict membrane protein oligomerization tomicroclusters, thenmeasure changes
in the cell. For instance, when cells expressing the receptor tyrosine kinase
EphA2 are placed on a supported lipid bilayer that contains the ligand ephrinA1,
the receptors bind the ligands and the complex reorganizes into large clusters.
Applying spatial perturbations to disrupt the reorganization of EphA2-
ephrinA1 clusters results in alterations of downstream signaling events. In par-
ticular, we found that recruitment of the metalloprotease ADAM10 to the clus-
ters is inhibited, indicating that EphA2 signaling is sensitive to perturbations in
the spatial organization of the ligand.ADAM10has been implicated in the cleav-
age and subsequent endocytosis of other ephrin ligands, suggesting that
ADAM10 may be necessary for the efficient endocytosis of EphA2-ephrinA1.
Therefore, our research is currently probing the role of endocytosis in the spatio-
mechanical sensitivity of EphA2. We will present our studies of receptor tyro-
sine kinase spatial organization in cancer cells as well as in other living systems.
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The tropomyosin-related kinase A (TrkA) receptor and its ligand, nerve growth
factor (NGF), play crucial roles in the development,maintenance and function of
the nervous system. NGF, which can form a stable dimer, is believed to activate
TrkA by bridging two TrkA monomers, leading to TrkA transphosphorylation
and signal transduction. However, studies using asymmetric NGFmimetics sug-
gest ligand binding may not be responsible for the receptor dimerization. In the
present study, therefore, we examined whether TrkA has a preformed homodi-
meric structure in living cells by using three different approaches, chemical
crosslinking, bimolecular fluorescence complementation (BiFC), and firefly lu-
ciferase fragment complementation. These analyses have demonstrated that the
majority of the TrkA receptor exists as a preformed, yet inactive, homodimer
prior to NGF binding. Furthermore, the TrkA homodimer was found to be de-
tected in endoplasmic reticulum (ER) before newly synthesized receptors reach
the cell surface. These findings shed light on molecular mechanisms underlying
transmembrane signaling by the neurotrophin receptor family.
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Growth hormone receptor (GHR) forms a central component of growth hor-
mone (GH) induced signaling pathways and is engaged in various cell functions
related to growth and metabolism. Despite its cardinal role in these functions,
knowledge of its structure is limited, especially for the transmembrane (TM)
domain that bridges extracellular signals to the cytosolic downstream recipi-
ents. To generate possible inactive and active state TM domain models, we per-
form two sets of replica-exchange simulations with human GHR TM domains.
The resulting representative structures are subjected to a total of 7.8 ms molec-
ular dynamics simulations in POPC bilayers to further explore their stability
and intrinsic dynamics. Structural analyses reveal differences in active and in-
active state TM structures and indicate that the activation/deactivation process
involves TM helix rotation and piston motion. In addition, a homology model-
ing study is conducted to construct a more complete model containing extracel-
lular and TM domains. From this model, a possible mechanism for GH binding
triggered TM domain reorganization is proposed. According to this mecha-
nism, GH binding poses steric constraints on the extracellular domain, altering
its interactions with the TM domain and leading the reorganization.
